Drugs. Trimethoprim lactate was dissolved (1 -3 mg per ml) in distilled water, giving a solution equivalent to 1.0 mg per ml of trimethoprim base. Sulphamethoxazole was dissolved in a minimal quantity of N-NaOH and then made up to volume with distilled water, Solutions were sterilised by filtration.
Cultures were grown overnight at 37°C in suitably supplemented Davis Mingioli medium (DM) (Davis and Mingioli, 1950) . They were then washed and resuspended in DM salts solution without glucose or amino acids (termed " DM base "). Between 1 and 2 x 10s cells from these washed suspensions were plated on to fully supplemented DM with added Tm (4 pg per ml) and thymine (60 pg per ml), solidified with 1.5 per cent. Davis Japanese agar. The plates were incubated for 48-72 hr, after which time trimethoprim-resistant clones had formed visible colonies. Subsequently, any requirement for thymine was checked by subcultivating the TmR mutants on supplemented DM with and without thymine (60 pg per ml). No growth was produced by thymine-requiring strains in the absence of thymine. For growth of E. coli J6-2, DM was supplemented with L-proline, L-histidine and L-tryptophan, each at a final concentration of 40 pg per ml. Salmonella typhimurium LT2 and E. coli serotype 0 1 11 were grown in unsupplemented DM, and S. enteritidis was grown in DM + 1 mg per ml vitamin-free Casamino Acids (Difco). D-Glucose (2.8 mg per ml) was used as the carbon source in all DM media.
Efect of R factors on mutation to joint Tm and Su resistance. R-factor-containing strains of E. coli 56-2 and the isogenic R-strains were grown overnight in 200-ml quantities of supplemented DM, with shaking. The cultures were washed with DM base, and finally resuspended in 10 ml of DM base; 0.3-ml and 0-1-ml quantities of this concentrated suspension, and similar volumes of tenfold dilutions in DM base, were plated on to supplemented DM +Tm (4 pg per ml) +Su (20 pg per ml), with or without thymine 60 pg per ml : any requirement for thymine was therefore assessed simultaneously with the emergence of drug resistance. The MIC of Tm for different strains was found by plating about 100 viable cells from washed overnight cultures on to suitably supplemented DM agar containing increasing concentrations of Tm. The MIC was taken as the lowest concentration of Tm that prevented the occurrence of any visible colony after 2 days' incubation.
Isolation of trimethoprim-resistant clones.
Estimation of minimum inhibitory concentration (MIC) of Tm.
RESULTS
The minimum inhibitory concentration of Tm was 0.4 pg per ml for both J6-2R-and 56-2 (R-7268); thus R-7268 does not confer resistance to Tm, although it does convey Su resistance (table I) .
DM media used for the selection of trimethoprim-resistant mutants was supplemented with thymine in preference to thymidine because Koch and Burchall (1971) have shown that the lattcr exerts a very marked antagonistic effect upon trimethoprim activity. We found that thymine at 60 pg per ml exerted only a small protective effect when included in this minimal medium, in that, although when it was present tiny colonies of both J6-2R-and J6-2(R-7268) could still be seen on MIC plates containing concentratioiis of Tm up to 1 pg per ml, no growth was observed at Tm concentrations of 2 pg per ml or greater.
The mutation rate to trimethoprim resistance, as judged by the ability of cells to form visible colonies on Tm, 4 pg per ml, was 3.3 x 10-7 for both J6-2R-and J6-2(R-7268) (table 11). After streaking on DM with and without thymine, all TmR clones tested were found to be thymine requiring (table 11) . Mutation rates to resistance to concentrations of Tm as high as 10 pg per ml were essentially the same as those for Tm, 4 pg per ml. Strains of S. typhimurium LT2, S. enteritidis and an enteropathogenic strain of E. coli (serotype 0 1 11, kindly supplied by Dr Naomi Datta) were found to mutate to trimethoprim resistance at similar rates to that of E. coli 56-2 (table 11). All TmR clones from the three enteropathogenic species were also found to require thymine (table II) , and it is therefore evident that this mode of development of resistance to trimethoprirn may be clinically significant. 
. S. after ultraviolet-light mutagenesis of E. coli 56-2 (R-7268).
$ A spontaneous loss mutant isolated in S. typhimurium LT2 by Margaret J. Thompson.
5 Tsolated by R. J. P. in E. coli J6-2 after mating with a thymineless strain of E. coli K12 that contained both R-1818 and R-TEM (Datta and Kontomichalou, 1965; Pinney and Smith, 1971 ). R-7268 and R-1818, which were originally isolated in Dr E. S. Anderson's laboratory, have been renamed R l and R46 respectively by Meynell and Datta (1966) . The mutation rate of J6-2R-to joint trimethoprim and sulphonamide resistance was tested and found to be outside the level of detection of the experiment ( t 2 . 8 x 10-11), regardless of the presence or absence of thymine.
Since mutation rates are cumulative, it is estimated that the rate of mutation of a doubly sensitive strain to joint TmR and SuR might well be of the order of 10-14. No TmRSuR clones were isolated when J6-2(R-7268) was plated on the combination without thymine, whereas when thymine was included, the frequency of mutation of J6-2(R-7268) from SuR to joint TmRSuR was found to be 2-8 x 10-7 (table 111). Since doubly resistant clones could be selected only when thymine was present, it appeared that they should all be thymine requiring. In support of this view, 38 colonies of E. coli 56-2(R-7268), all TmRSuR in character, were streaked on DM with and without thymine and all were found to be dependent on exogenous thymine for growth, i.e., were thymine requiring (table 111) . The mutation rate of J6-2(R-7268) to Tm resistance in the presence of sulphamethoxazole (2.8 x 10-7) agrees well with the rate of 3.3 x 10-7 for the mutation of both J6-2R-and 56-2(R-7268) to Tm resistance in the absence of the sulphonamide (table 11) .
Although E. coli J6-2 was used as the model organism in experiments to test how R factors could affect joint Su and Tm resistance (table 111) , it is evident from the results presented in table I1 that R-factor-containing enteropathogenic species would also give rise to joint TmRSuR bacteria at similar rates as sulphonamide-resistant R+ J6-2 strains. Two other R factors, R-18 18 and R-222 (table I) , which also convey sulphonamide resistance, were transferred into E. coli 56-2, and both were found to increase the frequency of occurrence of joint TmRSuR clones to a detectable level (table 111) . It is likely, therefore, that any R factor that carries sulphonamide resistance might facilitate the emergence of trimethoprim-resistant cells during combined treatment with trimethoprim and a sulphonamide. When R-7268 was transferred out of TmRSuR strains of J6-2 (R-7268) into E. coli K12, the recipients were found to be SuR but not TmR. The mutation to TmR is therefore not transferred with the R factor, and is probably a chromosomal mutation to thymine dependence. Derivatives of R-7268 and R-18 18 that have lost the ability to confer sulphonamide resistance were transferred into E. coli J6-2, and none of them permitted the occurrence of joint TmRSuR clones (table 111) . It may be concluded that the mere presence of an extrachromosomal element is insufficient for the demonstration of joint TmRSuR resistant cells; the plasmid must confer SuR on its host if cells that are resistant to combined trimethoprim and sulphonamide therapy are to occur at a detectable frequency.
DISCUSSION
It has been shown that Gram-negative bacteria, including S. typhi, S. enteritidis and two strains of E. coli, one of them belonging to the enteropathogenic serotype 0 1 1 1, can readily mutate to trimethoprim resistance. It was not possible to measure the frequency of mutation to joint trimethoprim and sulphamethoxazole resistance, presumably because such double mutations occur too rarely to be detected by the method used. Nevertheless, when bacteria harboured R factors conferring sulphonamide resistance, they became resistant to the combination of trimethoprim and sulphamethoxazole as readily as did the analogous R-strains to trimethoprim alone. This finding may well be of clinical significance.
Care should be taken in interpreting results of sensitivity tests made with combinations of trimethoprim and a sulphonamide. Organisms that harbour an R factor conferring sulphonamide resistance will be classified as sensitive to combinations of trimethoprim and a sulphonamide when tested, for example, by the disk method; but there is clearly a danger that during treatment mutants may arise that are resistant to the drug combination. Consequently, we recommend that organisms should also be tested for resistance to sulphonamides alone, since sulphonamide resistance in a strain implies a high risk of development of resistance to the drug combination and therefore represents a potential threat to the successful outcome of co-trimoxazole therapy.
Trimethoprim acts by blocking the enzyme dihydrofolate reductase, which catalyses the reduction of dihydrofolate to tetrahydrofolate. As far is known, the only metabolic pathway in which tetrahydrofolate is used in substrate amounts is the production of thymidylate by the methylation of deoxyuridylate. This reaction is catalysed by the enzyme thymidylate synthetase, which uses N5, Nlo-methylene-tetrahydrofolate as the methyl donor ; the latter is oxidised to dihydrofolate in the process (Hitchings, 1969) . All trimethoprimresistant clones isolated in this work were found to be dependent on exogenous thymine for growth, a requirement that has been shown to be due to a deletion or mutation in the gene coding for thymidylate synthetase. Since thymine-requiring organisms are incapable of the synthesis of thymine de now, they do not require substrate amounts of tetrahydrofolate, and are therefore relatively immune to the inhibition of dihydrofolate reductase by t rimetho prim.
The concentrations of available thymine or thymidine present in infected tissues are not known, but the fact that few trimethoprim-resistant strains isolated from clinical sources are found to be thymine requiring (Dr Naomi Datta, personal communication) suggests that they may be low. However, the low frequency of isolation of thymine-requiring organisms may be more apparent than real. Some laboratory media are deficient in thymidine (Koch and Burchall, 1971 ) and unless such media are supplemented by the addition of thymidine or thymine this class of trimethoprim-resistant mutants will escape detection on them.
? Thymidine reverses the antimicrobial activity of trimethoprim on wild-type strains that do not require thymine (Koch and Burchall) . Wild-type bacteria take up thymine less readily than thymidine (Crawford, 1958 ; Kammen, 1967) , and hence the addition of thymine to media used for trimethoprim sensitivity testing might permit the growth of thymine-requiring strains without simultaneously antagonising the activity of trimethoprim against wild-type organisms. However, S. G. B. Amyes and J. T. Smith (unpublished observations) have found that the presence of trimethoprim in complex media appears to facilitate the uptake of thymine by wild-type bacteria. Consequently it is inadvisable to add thymine or thymidine to media used for trimethoprim sensitivity testing, since the inclusion of either will render sensitive strains apparently resistant to trimethoprim. We recommend that strains from patients undergoing trimethoprim therapy should be isolated on media supplemented with thymine or thymidine and their growth requirements subsequently checked by streaking on a medium deficient in thymidine, such as Wellcome nutrient agar (Koch and Burchall) . Work is being continued to elucidate the problems of isolation of these mutants SUMMARY Gram-negative bacteria, harbouring R factors that confer resistance to sulphonamides, mutate to trimethoprim resistance at an appreciable rate and are then able to grow in the presence of both trimethoprim and a sulphonamide.
All trimethoprim-resistant organisms isolated in this study were thymine requiring, and it is suggested that the frequency of isolation of organisms resistant to trimethoprim, or combinations of trimethoprim and a sulphonamide, may be increased if adequate thymine or thymidine is included in the media used for their isolation.
